This content is machine translated SGLT2 inhibitors Clear, simple language improves patient safety Sodium-glucose cotransporter 2 inhibitors (SGLT2i) were initially indicated as blood glucose-lowering drugs for type 2 diabetes. They are now widely used as first-line therapies for various indications, particularly heart failure...…
View Post 2 min This content is machine translated High-dose influenza vaccine Lower hospitalization rates – even with heart failure The results of a pre-specified exploratory analysis of the DANFLU-2 study indicate that the administration of a high-dose inactivated influenza vaccine could provide additional protection in patients with cardiovascular disease....…
View Post 5 min This content is machine translated Heart failure: combination of four as "Guideline-Directed Medical Therapy" Standard established at HFrEF with individual nuances The modern treatment of heart failure is characterized by early intervention, multidimensional care and extended therapy options. Around half of all heart failure patients have a reduced left ventricular ejection...…
View Post 5 min This content is machine translated Underestimated risk - findings from a US cohort Heart failure after myocardial infarction Acute myocardial infarction is now considered more treatable than ever. However, despite optimized reperfusion, modern pharmacotherapies and improved care systems, one risk remains that is underestimated in many clinical procedures:...…
View Post 6 min This content is machine translated Dapagliflozin for T2D and heart failure Epicardial fat reduced in patients with type 2 diabetes and HF The co-occurrence of heart failure (HF) and diabetes leads to a higher risk of complications, higher mortality and worse outcomes than either disease alone. Studies have shown the importance of...…
View Post 9 min This content is machine translated Type 2 diabetes and heart failure: a bidirectional relationship Proactive preventive measures can reduce the burden of disease Heart failure and diabetes mellitus are two of the greatest global health burdens and their prevalence is steadily increasing. At the same time, heart failure is becoming one of the...…
View Post 8 min This content is machine translated HFpEF 2025 Precision medicine and phenotypes In 2025, heart failure with preserved ejection fraction (HFpEF) is less than ever a single clinical picture – it is an umbrella over many phenotypes with different triggers, pathomechanisms and...…
View Post 4 min This content is machine translated Journal Club: Drinking restriction in heart failure First large-scale study found no differences Patients with heart failure are often recommended to drink a maximum of 1.5 liters of fluid per day. However, the benefits of this measure have hardly been scientifically proven to...…
View Post 19 min This content is machine translated Cardiovascular risk and obesity Pathomechanisms, secondary prevention and treatment options Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right...… CME-Test
View Post 4 min This content is machine translated Heart failure Gradually expand drug therapy! Chronic heart failure mainly occurs in older people. The drug therapy options available today represent a decisive advance in treatment options. According to current ESC guideline recommendations, it is advisable...…
View Post 19 min This content is machine translated Cardiovascular risk and obesity Pathomechanisms, secondary prevention and treatment options Obesity is not only a well-known, significant risk factor for the development and progression of cardiovascular disease (CVD), but is also recognized as a disease entity in its own right...… CME-Test
